270 related articles for article (PubMed ID: 9382365)
1. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
[TBL] [Abstract][Full Text] [Related]
2. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
Bizollon T; Ahmed SN; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
Gut; 2003 Feb; 52(2):283-7. PubMed ID: 12524414
[TBL] [Abstract][Full Text] [Related]
3. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
Shindo M; Arai K; Sokawa Y; Okuno T
Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
[TBL] [Abstract][Full Text] [Related]
4. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH
Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
[TBL] [Abstract][Full Text] [Related]
6. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.
Kakumu S; Yoshika K; Tanaka K; Higashi Y; Kurokawa S; Hirofuji H; Kusakabe A
J Med Virol; 1993 Sep; 41(1):65-70. PubMed ID: 8228941
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon-alfa therapy in children with chronic hepatitis C.
Bortolotti F; Giacchino R; Vajro P; Barbera C; Crivellaro C; Alberti A; Nebbia G; Zancan L; De Moliner L; Bertolini A
Hepatology; 1995 Dec; 22(6):1623-7. PubMed ID: 7489965
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus RNA and long-term response to recombinant interferon-alpha 2b in patients with chronic hepatitis C.
Tanno H; Fernández JL; Rendo P; del Pino N; Viola L; Terg R; Pérez V
J Viral Hepat; 1995; 2(2):97-102. PubMed ID: 7493304
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up.
Diodati G; Bonetti P; Tagger A; Casarin C; Noventa F; Ribero M; Fasola M; Ruol A; Realdi G
Dig Dis Sci; 1994 Nov; 39(11):2497-502. PubMed ID: 7525169
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.
Pol S; Thiers V; Carnot F; Zins B; Romeo R; Berthelot P; Bréchot C
Kidney Int; 1995 May; 47(5):1412-8. PubMed ID: 7637270
[TBL] [Abstract][Full Text] [Related]
12. Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon.
Marcellin P; Boyer N; Degott C; Martinot-Peignoux M; Duchatelle V; Giostra E; Areias J; Erlinger S; Benhamou JP
Liver; 1994 Dec; 14(6):302-7. PubMed ID: 7877434
[TBL] [Abstract][Full Text] [Related]
13. Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.
Yun ZB; Reichard O; Chen M; Lundeberg J; Norkrans G; Fryden A; Sönnerborg A; Weiland O
Scand J Infect Dis; 1994; 26(3):263-70. PubMed ID: 7939425
[TBL] [Abstract][Full Text] [Related]
14. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
Shindo M; Di Bisceglie AM; Hoofnagle JH
Hepatology; 1992 Jun; 15(6):1013-6. PubMed ID: 1317338
[TBL] [Abstract][Full Text] [Related]
16. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.
Orito E; Mizokami M; Suzuki K; Ohba K; Ohno T; Mori M; Hayashi K; Kato K; Iino S; Lau JY
J Med Virol; 1995 Jun; 46(2):109-15. PubMed ID: 7636496
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
[TBL] [Abstract][Full Text] [Related]
18. Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection.
Lau DT; Negash A; Chen J; Crochet N; Sinha M; Zhang Y; Guedj J; Holder S; Saito T; Lemon SM; Luxon BA; Perelson AS; Gale M
Gastroenterology; 2013 Feb; 144(2):402-413.e12. PubMed ID: 23123437
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
20. Short and long-term effects of interferon on serum markers of hepatitis C virus replication.
Yatsuhashi H; Inoue O; Inokuchi K; Koga M; Nagataki S; Cha TA; Irvine B; Stempien M; Kolberg J; Urdea MS
J Gastroenterol Hepatol; 1993; 8(1):1-6. PubMed ID: 8382537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
